#USA #Medical Imaging #Aignostics #PathoSearch #Berlin / New York

PathoSearch: A New Era in Pathology

Aignostics has officially announced the early access launch of PathoSearch, an innovative visual search engine specifically designed for pathology cases. This groundbreaking tool allows pathologists to streamline their diagnostic processes by utilizing visual image search capabilities. With a simple screenshot from a tissue slide, PathoSearch connects researchers and clinicians to a vast database of previously diagnosed cases, aiding them in recognizing similar morphological patterns.

The Challenge for Pathologists

In the field of pathology, clinicians often encounter rare and complex cases that can account for nearly 20% of their workload. Traditionally, obtaining a second opinion or finding comparable reference cases has been a time-consuming venture, often requiring digital sharing of images or shipping physical slides. This cumbersome process can delay results significantly, placing both clinicians and patients in challenging positions. Dr. Simon Schallenberg from Charité – Universitätsmedizin Berlin underscores this frustration, noting that the lengthy time frames associated with obtaining complex case evaluations can hinder timely patient care.

How PathoSearch Works

PathoSearch optimizes the diagnostic workflow by leveraging an exclusive multicentric database, powered by a proprietary AI model called Atlas 2—developed in collaboration with the Mayo Clinic. Pathologists can input a screenshot from their imaging software, and PathoSearch will retrieve matches from its extensive library of over 310,000 annotated and validated cases that encompass more than 300 diagnostic entities across various organs.

This integration not only provides quick access to reference cases but also allows pathologists to conduct differential diagnostics in a matter of minutes, significantly outperforming traditional methods. Each case returned by the system is validated by experienced pathologists and often includes molecular testing confirmation, enhancing confidence in diagnostic capabilities.

Expanding the Database

Aignostics aims to expand the PathoSearch database to exceed one million whole slide images by the time it is publicly available. The current dataset focuses on malignancies, adhering to WHO classification standards, and encompasses various organ groups, including thoracic, gastrointestinal, soft tissue, and reproductive organs.

Collaboration and Integration

PathoSearch can be integrated within various image management systems, with its first implementation within Techcyte Fusion® AP. Pathologists using Fusion are encouraged to reach out for a demonstration on how to utilize this feature effectively. Currently, PathoSearch is available for free for those participating in the early access program, with an expectation for full-scale deployment in the near future.

Conclusion

PathoSearch marks a transformative advancement in the realm of diagnostic-pathology. As clinicians continue to face the challenges posed by rare cases and collaborative diagnostics, tools like PathoSearch promise to enhance efficiency and foster faster, evidence-based decision-making. For pathologists interested in redefining their diagnostic experience, Aignostics invites them to join the early access program by registering on their website. Note: PathoSearch is exclusively intended for scientific use and not for diagnostic procedures.

About Aignostics

Founded in 2020 and headquartered in both Berlin and New York, Aignostics specializes in AI-driven tissue analysis validated by professional pathologists. The company's pioneering integration of exclusive multimodal clinical data and cutting-edge technology aims to revolutionize precision medicine, providing essential tools for both biopharmaceutical R&D and clinical diagnostics. Notable investors include the Mayo Clinic, presenting a robust backing for their innovative endeavors. For more information, visit Aignostics.